ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.575
-0.065 (-3.96%)
Apr 29, 2026, 2:14 PM EDT - Market open

ALX Oncology Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-101.7-134.85-160.81-123.48-83.46
Upgrade
Depreciation & Amortization
0.710.870.840.340.05
Upgrade
Other Amortization
0.280.270.250.04-
Upgrade
Loss (Gain) From Sale of Assets
-0.01---
Upgrade
Asset Writedown & Restructuring Costs
3.18----
Upgrade
Loss (Gain) From Sale of Investments
-1.24-4.66-6.49-0.94-
Upgrade
Stock-Based Compensation
12.5827.0926.2723.8413.91
Upgrade
Other Operating Activities
1.721.791.271.125.42
Upgrade
Change in Accounts Payable
0.42-4.020.464.513.29
Upgrade
Change in Other Net Operating Assets
-0.09-8.417.845.34-7.32
Upgrade
Operating Cash Flow
-84.14-121.91-130.36-89.22-68.1
Upgrade
Capital Expenditures
-0.21-0.45-1.27-1.43-0.67
Upgrade
Sale (Purchase) of Intangibles
-----4.26
Upgrade
Investment in Securities
82.886.745.93-233.99-
Upgrade
Investing Cash Flow
82.5986.2644.66-235.42-4.92
Upgrade
Long-Term Debt Issued
---10-
Upgrade
Long-Term Debt Repaid
-1.36-0.83-0.39-0.39-0.28
Upgrade
Net Debt Issued (Repaid)
-1.36-0.83-0.399.61-0.28
Upgrade
Issuance of Common Stock
0.041.9864.040.92.75
Upgrade
Other Financing Activities
1.6929.66-4.36-0.66-
Upgrade
Financing Cash Flow
0.3630.8259.299.862.47
Upgrade
Net Cash Flow
-1.19-4.84-26.42-314.78-70.55
Upgrade
Free Cash Flow
-84.35-122.36-131.64-90.65-68.77
Upgrade
Free Cash Flow Per Share
-1.57-2.35-3.06-2.23-1.71
Upgrade
Cash Interest Paid
1.261.391.180.10.01
Upgrade
Cash Income Tax Paid
----0.27
Upgrade
Levered Free Cash Flow
-50.61-80.95-74.8-44.64-36.42
Upgrade
Unlevered Free Cash Flow
-49.89-80.13-74.07-44.53-36.41
Upgrade
Change in Working Capital
0.34-12.438.39.85-4.03
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.